Trk-IN-9
Trk-IN-9 (Compound 12) is a potent inhibitor of TRK. Trk-IN-9 inhibits the proliferation of Km-12 cell lines. Trk-IN-9 induces the apoptosis of Km-12 cells in a concentration-dependent manner. Trk-IN-9 inhibits the phosphorylation of TRK to block downstream pathways. Trk-IN-9 has the potential for the research of NTRK-fusion cancers[1].
Product Specifications
CAS Number
2758623-12-8
UNSPSC
12352005
Target
Trk Receptor
Type
Reference compound
Related Pathways
Neuronal Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/trk-in-9.html
Solubility
10 mM in DMSO
Smiles
FC1=CC=CC(CNC2=NC(NC3=CC(C(N[C@@H]4CCCNC4)=O)=CC=C3)=NC=C2Cl)=C1
Molecular Formula
C23H24ClFN6O
Molecular Weight
454.93
References & Citations
[1]Wu T, et al. Rational drug design to explore the structure-activity relationship (SAR) of TRK inhibitors with 2,4-diaminopyrimidine scaffold. Eur J Med Chem. 2022;230:114096.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC882445-500 1x 500 µL
GATA-3 (Breast and Urothelial Marker) (GATA3/2445), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880354-100 1x 100 µL
AFP (Alpha Fetoprotein) (C3), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
